Publications

5674 Results

Pathologic evaluation of radical cystectomy specimens: a Cooperative Group report

Authors
HW Herr;JR Faulkner;HB Grossman;ED Crawford
Journal / Conference
Cancer 100(11):2470-2475
Year
2004
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8710 (INT-0080) (EST-1887) (CALGB-8891)

Statistical design issues and other practical considerations for conducting phase III prostate cancer prevention trials

Authors
CM Tangen;PJ Goodman;JJ Crowley;IM Thompson
Journal / Conference
Journal of Urology 171:S64-S67
Year
2004
Research Committee(s)
Cancer Control, Prevention, Screening, and and Surveillance
Study Number(s)
S0000, SWOG-9217

A phase II study of cisplatin preceded by a 12-hour continuous infusion of concurrent hydroxyurea and cytosine arabinoside (Ara-C) for adult patients with malignant gliomas

Authors
H Carraway;LJ Swinnen;C Rankin;KS Albain;JJ Townsend;D Blumenthal
Journal / Conference
Neuro-Oncology 6(4):372 (TA-10)
Year
2004
Research Committee(s)
Brain
Study Number(s)
SWOG-9149

Bronchioloalveolar carcinoma: a model for investigating the biology of epidermal growth factor receptor inhibition

Authors
DR Gandara;H West;K Chansky;AM Davies;DHM Lau;J Crowley;PH Gumerlock;FR Hirsh;WA Franklin
Journal / Conference
Clinical Cancer Research 10 (Suppl):4205s-4209s
Year
2004
Research Committee(s)
Lung
Study Number(s)
S0126, S9714

Cholesterol synthesis and import contribute to protective cholesterol increments in acute myeloid leukemia cells

Authors
DE Banker;SJ Mayer;HY Li;CL Willman;FR Appelbaum;RA Zager
Journal / Conference
Blood 104(6):1816-1824
Year
2004
Research Committee(s)
Leukemia

Phase II trial of vinorelbine for relapsed ovarian cancer. A Southwest Oncology Group Study

Authors
ML Rothenberg;PY Liu;S Wilczynski;WA Nahhas;GL Winakur;C Jiang;CM Moinpour;B Lyons;GR Weiss;JH Essell;HO Smith;M Markman;DS Alberts
Journal / Conference
Gynecologic Oncology 95:506-512
Year
2004
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-9324

Participant's perception of recruitment and retention in the selenium and vitamin E cancer prevention trial

Authors
D Banerjee;JM Choe;D Ward;AM Hoque;K Basen-Engquist;J Song;D Ramsey;SM Lippman;ED Cook
Journal / Conference
Proc of AACR Frontiers in Cancer Prevention Research, Oct 16-20:131 (#884)
Year
2004
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000

Expression of VEGF, VEGF receptors, and other angiogenic markers in relapsed aggressive non-Hodgkin's lymphoma: correlative studies from the SWOG S0108 trial

Authors
A Stopeck;M Iannone;L Rimsza;T Miller;R Fisher;W Bellamy
Journal / Conference
Blood 104(11): #2288
Year
2004
Research Committee(s)
Lymphoma
Study Number(s)
S0108

Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck

Authors
JS Cooper;TF Pajak;AA Forastiere;J Jacobs;BH Campbell;SB Saxman;JA Kish;HE Kim;AJ Cmelak;M Rotman;M Machtay;JF Ensley;KSC Chao;CJ Schultz;N Lee;KK Fu
Journal / Conference
New England Journal of Medicine 350(19):1937-1944
Year
2004
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-9515 (RTOG-9501)

SWOG S0119: a phase II study of gemcitabine and irinotecan for patients with untreated extensive stage small cell lung cancer (SCLC)

Authors
WL Akerley;J McCoy;P Hesketh;J Crowley;L Kaye;D Gandara
Journal / Conference
Proc of the American Society of Clinical Oncology 23:663 (#7202)
Year
2004
Research Committee(s)
Lung
Study Number(s)
S0119